US provider directory / Profile

ReflexMD

Direct-to-consumer telehealth program advertising compounded weight-management treatment with digital clinician review.

Leer el resumen en español ↓
  • Private pay
  • Compounded route
  • Clinician review
  • Switching support
Research checkedSep 13, 2026
4 cited sourcesUS profile
Editorial note

This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.

At a glance

Price viewMonthly cash price; verify dose termsConfirm whether the amount changes by dose, term, or promotion and what is included.
Payment routesCash payThe reviewed model is direct cash pay.
Medicines and brand contextSemaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes)Only if prescribed, appropriate, and available for the relevant indication.
GeographyUS multi-state; confirm at intakeConfirm during intake.
Service modelAll-in cash-pay programTelehealth program
Format and supportInjectionClinician support · Switching pathway · Home delivery
Evidence reviewed4 cited sources

Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.

Still to confirm5 open checks

An open check means the public sources were not specific enough—not that the service failed the check.

Resumen en español

ReflexMD para usuarios hispanohablantes

Idioma de la consulta no confirmado

Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.

Mercado revisadoEstados Unidos
Forma de pagoPago directo
Ruta publicadaPreparación compuesta
Idioma de la atención

No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.

Antes de pagar, confirma:
  • si la cita concreta será en español;
  • el coste mensual ordinario y qué incluye;
  • la licencia estatal del profesional;
  • el medicamento, la farmacia y el coste por separado.

Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.

Comparar proveedores para hispanohablantes en EE. UU. →

How the program is structured

An all-in subscription connecting patients to board-certified physicians in every state. The help center confirms that virtual consultation, medication, and shipping are included, but current product prices require entering the eligibility flow.

GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.

Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.

Research confidence Limited Confidence reflects public-source specificity, not clinical quality.

Service configuration

These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.

Provider type
Telehealth program
Medicine context
Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes)
Formats reviewed
Injection
Funding routes
Private pay
Service features
Clinician support · Switching pathway · Home delivery
Access check
Provider coverage published; confirm treatment
Evidence status
Primary sources reviewed
Research depth
4 cited sources · 1 medicine row · 5 open checks

Recurring cost breakdown

  • Subscription includes the virtual consultation, prescribed medication, and shipping.
  • Multiple products and pricing plans are offered; current amounts are shown only after selecting Get Started or See if I Qualify.
  • No separate membership layer is disclosed in the help-center inclusion answer.
  • Potential dose or term price changes must be confirmed in the patient-specific offer.
Build the actual monthly total from
  • Medicine + dose
  • Membership or consultation
  • Delivery + supplies
  • Labs + follow-up
  • Renewal after offers

Medication and formulation matrix

MedicationFormRegulatory / program pathPublished price view
Personalized semaglutide programConfirm in eligibility flowCompounded route advertised; not FDA-approvedNot public; shown after eligibility flow

Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.

State-by-state availability

  • ReflexMD says its physician network serves every state.
  • A specific product or pharmacy can still be unavailable in a given state.

Clinician access and follow-up cadence

  • Board-certified physician consultation is included.
  • Wellness Advisors provide education and motivation.
  • A fixed refill, live-visit, or response-time schedule is not public in the reviewed help pages.

Pharmacy and fulfillment

  • Shipping is included.
  • The named dispensing pharmacy, formulation, and replacement policy are not publicly confirmed in the reviewed pages.

Insurance and prior authorization

  • The model appears direct pay; no public prior-authorization workflow was confirmed.
  • Ask whether HSA/FSA payment is accepted and what documentation is supplied.

Cancellation, refund, and commitment

  • Public cancellation and refund timing were not located in the reviewed help-center answers.
  • Confirm the renewal date and pharmacy-order cutoff before subscribing.

Labs, monitoring, and dose management

  • No universal lab panel or included lab service was confirmed.
  • Ask what monitoring is required for the exact formulation.

Maintenance and switching

  • Every-state physician access may support transfers, but current-dose continuation is not guaranteed.
  • Confirm records and refill timing in writing before changing providers.

Program snapshot

Care model

All-in cash-pay program

Profiled support: Ongoing clinician access, Simplified intake and fulfillment.

Payment and coverage

Cash pay

The reviewed model is direct cash pay.

Pharmacy and fulfillment

Verify before purchase

Request the dispensing pharmacy, formulation, shipping protocol, and replacement policy.

What the advertised program may include

  • Digital intake
  • Clinician review
  • Medication when prescribed
  • Shipping according to plan

Useful comparison signals

Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.

  • Starting care and comparing first-provider requirements
  • Switching providers or continuing an established treatment
  • Comparing lower-cost access routes and recurring totals
  • Ongoing clinician access
  • Simplified intake and fulfillment

Open evidence gaps

These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.

  • Public price table
  • Named dispensing pharmacy
  • Cancellation/refund policy
  • State-by-product table
  • Lab and follow-up cadence

Questions to ask before paying

  1. What is the ordinary recurring total after any introductory period?
  2. Does that total include clinician care, medication, supplies, labs, and shipping?
  3. Which clinician group and dispensing pharmacy will be responsible for my care?
  4. What happens to billing if I am not prescribed the advertised treatment?
  5. What records and timing do you require if I am switching from another provider?

Source ledger

Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.